Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival-Reference-Cited by-同舟云学术

Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival

Published:2022-02-04 Issue:2 Volume:29 Page:79-91
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Kharoubi Mounira¹²³⁴,Bodez Diane¹²³⁴⁵,Bézard Mélanie¹²³⁴,Zaroui Amira¹²³⁴,Galat Arnault¹²³⁴,Guendouz Soulef¹²³⁴,Gendre Thierry¹²⁶,Hittinger Luc¹²³⁴,Attias David⁵,Mohty Dania⁷⁸,Bergoend Eric⁹,Itti Emmanuel¹²¹⁰,Lebras Fabien¹²¹¹,Hamon David¹²³⁴,Poullot Elsa¹²¹²,Molinier-Frenkel Valérie¹²¹²¹³,Lellouche Nicolas¹²³⁴,Deux Jean-François¹²¹⁴,Funalot Benoit¹²¹⁵,Fannen Pascale¹²¹⁵,Oghina Silvia¹²³⁴,Arrouasse Raphael¹²¹⁶,Lecorvoisier Philippe¹²¹⁶,Souvannanorath Sarah¹²¹⁷,Amiot Aurelien¹⁸,Teiger Emmanuel¹²³⁴,Bougouin Wulfran¹⁹²⁰,Damy Thibaud¹²³⁴¹⁶

Affiliation:

1. National Referral Center for Cardiac Amyloidosis, Creteil, France

2. GRC Amyloid Research Institute University Paris-Est Creteil INSERM, IMRB, Creteil, France

3. AP-HP, Department of Cardiology, Henri Mondor University Hospital, Creteil, France

4. Inserm U955, IMRB, Creteil, France

5. Centre Cardiologique du Nord, Saint Denis, France

6. AP-HP, Department of Neurology, Henri Mondor University Hospital, Creteil, France

7. Department of Cardiology, Dupuytren University Hospital, Limoges, France

8. AL Amyloidosis Referral Center, Dupuytren University Hospital, Limoges, France

9. AP-HP, Department of Cardiac Surgery, Henri Mondor University Hospital, Creteil, France

10. AP-HP, Department of Nuclear Medicine, Henri Mondor University Hospital, Creteil, France

11. AP-HP, Lymphoid Malignancy Unit, Henri Mondor University Hospital, Creteil, France

12. AP-HP, Department of Biology–Pathology, Henri Mondor Univ Paris Est Creteil, INSERM, IMRB, Creteil, France

13. AP-HP, Department of Immunobiology, Henri Mondor University Hospital, Créteil, France

14. AP-HP, Department of Radiology, Henri Mondor University Hospital, Créteil, France

15. AP-HP, Department of Genetic, Henri Mondor Teaching Hospital, Créteil, France

16. Inserm, Clinical Investigations Center 1430, AP-HP, DMU Saphire, Henri Mondor University Hospital, Creteil, France

17. AP-HP, Referral Center for Neuromuscular Disease Department, Henri Mondor University Hospital, Créteil, France

18. Department of Gastroenterology, Henri Mondor University Hospital, AP-HP, EA7375, University Paris-Est Creteil, Creteil, France

19. AP-HP, Centre de Recherche Cardiovasculaire de Paris (PARCC), INSERM U970, Centre d’Expertise Mort Subite (CEMS), Paris Descartes University, Paris, France

20. Ramsay Générale de Santé, Hôpital Privé Jacques Cartier, Massy, France

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2021.2013193

Reference39 articles.

1. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

2. Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)

3. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

4. Systemic Cardiac Amyloidoses

5. When and how do patients with cardiac amyloidosis die?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic implications of premature ventricular contractions and non-sustained ventricular tachycardia in light-chain cardiac amyloidosis;Europace;2024-03-01

2. Cardiac morbidity and the cause of death in elderly patients with prostate cancer and incidental cardiac uptake on bone scintigraphy;Clinical Physiology and Functional Imaging;2023-07-12

3. Amylose cardiaque à transthyrétine une maladie du XXIe siècle : du diagnostic au traitement;Bulletin de l'Académie Nationale de Médecine;2023-05

4. Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure;ESC Heart Failure;2023-04-13